Haloperidol hydrochloride

• Supplier: Tocris Bioscience
• Catalog: 0282
• Prices: $75.00
• Sizes: 100 mg
• Function Type: Antagonist
• Cas Number: 1511-16-6
• Chemical Name: 4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanonehydrochloride
• Formula: C21H23ClFNO2.HCl
• Molecular Weight: 412.33
• Purity: >99 %
• Description: Dopamine antagonist with selectivity for D 2 -like receptors (K i values are 1.2, ~ 7, 2.3, ~ 80 and ~ 100 nM for D 2 , D 3 , D 4 , D 1 and D 5 receptors respectively). Subtype-selective NMDA antagonist.

Product References

Haloperidol decanoate. A preliminary review of its pharmacodynamic and - Haloperidol decanoate. A preliminary review of its pharmacodynamic and

Beresford R, Ward A. Drugs. 1987 Jan;33(1):31-49.

Dopamine receptor pharmacology. - Dopamine receptor pharmacology.

Seeman P, Van Tol HH. Trends Pharmacol Sci. 1994 Jul;15(7):264-70.

Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol. - Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.

Ilyin VI, Whittemore ER, Guastella J, Weber E, Woodward RM. Mol Pharmacol. 1996 Dec;50(6):1541-50.

Inhibition of N-methyl-D-aspartate receptors by haloperidol: developmental and - Inhibition of N-methyl-D-aspartate receptors by haloperidol: developmental and

Lynch DR, Gallagher MJ. J Pharmacol Exp Ther. 1996 Oct;279(1):154-61.